Annual Net Income
-$219.71 M
-$255.09 M-721.02%
31 December 2023
Summary:
Cartesian Therapeutics annual net profit is currently -$219.71 million, with the most recent change of -$255.09 million (-721.02%) on 31 December 2023. During the last 3 years, it has fallen by -$150.83 million (-218.99%). RNAC annual net income is now -721.02% below its all-time high of $35.38 million, reached on 31 December 2022.RNAC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$24.18 M
-$38.02 M-274.78%
01 September 2024
Summary:
Cartesian Therapeutics quarterly net profit is currently -$24.18 million, with the most recent change of -$38.02 million (-274.78%) on 01 September 2024. Over the past year, it has dropped by -$15.18 million (-168.64%). RNAC quarterly net income is now -184.03% below its all-time high of $28.78 million, reached on 01 March 2022.RNAC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$244.83 M
-$15.18 M-6.61%
01 September 2024
Summary:
Cartesian Therapeutics TTM net profit is currently -$244.83 million, with the most recent change of -$15.18 million (-6.61%) on 01 September 2024. Over the past year, it has dropped by -$208.67 million (-577.09%). RNAC TTM net income is now -686.77% below its all-time high of $41.73 million, reached on 01 September 2022.RNAC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -721.0% | -168.6% | -577.1% |
| 3 y3 years | -219.0% | -35.1% | -358.7% |
| 5 y5 years | -236.3% | -101.6% | -344.2% |
RNAC Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -721.0% | at low | -184.0% | +86.4% | -686.8% | +3.9% |
| 5 y | 5 years | -721.0% | at low | -184.0% | +86.4% | -686.8% | +3.9% |
| alltime | all time | -721.0% | at low | -184.0% | +86.4% | -686.8% | +3.9% |
Cartesian Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.18 M(-274.8%) | -$244.83 M(+6.6%) |
| June 2024 | - | $13.84 M(-124.3%) | -$229.65 M(-9.9%) |
| Mar 2024 | - | -$56.82 M(-68.0%) | -$254.87 M(+16.0%) |
| Dec 2023 | -$219.71 M(-721.0%) | -$177.66 M(+1873.5%) | -$219.71 M(+507.6%) |
| Sept 2023 | - | -$9.00 M(-20.9%) | -$36.16 M(+3.2%) |
| June 2023 | - | -$11.39 M(-47.4%) | -$35.05 M(+132.7%) |
| Mar 2023 | - | -$21.66 M(-467.6%) | -$15.06 M(-142.6%) |
| Dec 2022 | $35.38 M(-237.7%) | - | - |
| Dec 2022 | - | $5.89 M(-174.7%) | $35.38 M(-15.2%) |
| Sept 2022 | - | -$7.89 M(-191.8%) | $41.73 M(+31.5%) |
| June 2022 | - | $8.60 M(-70.1%) | $31.72 M(+14.6%) |
| Mar 2022 | - | $28.78 M(+135.1%) | $27.69 M(-207.8%) |
| Dec 2021 | -$25.69 M(-62.7%) | $12.24 M(-168.4%) | -$25.69 M(-51.9%) |
| Sept 2021 | - | -$17.89 M(-492.0%) | -$53.37 M(+18.1%) |
| June 2021 | - | $4.57 M(-118.6%) | -$45.21 M(-38.8%) |
| Mar 2021 | - | -$24.60 M(+59.2%) | -$73.85 M(+7.2%) |
| Dec 2020 | -$68.88 M(+24.4%) | -$15.45 M(+58.8%) | -$68.88 M(+0.8%) |
| Sept 2020 | - | -$9.73 M(-59.6%) | -$68.32 M(-3.2%) |
| June 2020 | - | -$24.08 M(+22.7%) | -$70.58 M(+12.2%) |
| Mar 2020 | - | -$19.62 M(+31.8%) | -$62.90 M(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$55.35 M(-15.3%) | -$14.89 M(+24.1%) | -$55.35 M(+0.4%) |
| Sept 2019 | - | -$11.99 M(-26.8%) | -$55.11 M(-6.8%) |
| June 2019 | - | -$16.39 M(+35.8%) | -$59.12 M(-3.9%) |
| Mar 2019 | - | -$12.07 M(-17.6%) | -$61.52 M(-5.8%) |
| Dec 2018 | -$65.34 M(+0.0%) | -$14.65 M(-8.4%) | -$65.34 M(-7.0%) |
| Sept 2018 | - | -$16.00 M(-14.9%) | -$70.23 M(+1.9%) |
| June 2018 | - | -$18.80 M(+18.3%) | -$68.90 M(+4.3%) |
| Mar 2018 | - | -$15.89 M(-18.7%) | -$66.08 M(+1.2%) |
| Dec 2017 | -$65.32 M(+80.4%) | -$19.54 M(+33.2%) | -$65.32 M(+9.1%) |
| Sept 2017 | - | -$14.68 M(-8.1%) | -$59.86 M(+13.1%) |
| June 2017 | - | -$15.97 M(+5.5%) | -$52.91 M(+20.6%) |
| Mar 2017 | - | -$15.13 M(+7.5%) | -$43.87 M(+21.1%) |
| Dec 2016 | -$36.21 M(+43.8%) | -$14.08 M(+82.2%) | -$36.21 M(+25.0%) |
| Sept 2016 | - | -$7.73 M(+11.6%) | -$28.98 M(+7.4%) |
| June 2016 | - | -$6.92 M(-7.4%) | -$26.97 M(+0.2%) |
| Mar 2016 | - | -$7.48 M(+9.2%) | -$26.92 M(+6.9%) |
| Dec 2015 | -$25.17 M(+95.5%) | -$6.85 M(+19.6%) | -$25.17 M(+37.4%) |
| Sept 2015 | - | -$5.72 M(-16.6%) | -$18.32 M(+45.4%) |
| June 2015 | - | -$6.87 M(+19.8%) | -$12.60 M(+119.8%) |
| Mar 2015 | - | -$5.73 M | -$5.73 M |
| Dec 2014 | -$12.88 M | - | - |
FAQ
- What is Cartesian Therapeutics annual net profit?
- What is the all time high annual net income for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual net income year-on-year change?
- What is Cartesian Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly net income year-on-year change?
- What is Cartesian Therapeutics TTM net profit?
- What is the all time high TTM net income for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM net income year-on-year change?
What is Cartesian Therapeutics annual net profit?
The current annual net income of RNAC is -$219.71 M
What is the all time high annual net income for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual net profit is $35.38 M
What is Cartesian Therapeutics annual net income year-on-year change?
Over the past year, RNAC annual net profit has changed by -$255.09 M (-721.02%)
What is Cartesian Therapeutics quarterly net profit?
The current quarterly net income of RNAC is -$24.18 M
What is the all time high quarterly net income for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly net profit is $28.78 M
What is Cartesian Therapeutics quarterly net income year-on-year change?
Over the past year, RNAC quarterly net profit has changed by -$15.18 M (-168.64%)
What is Cartesian Therapeutics TTM net profit?
The current TTM net income of RNAC is -$244.83 M
What is the all time high TTM net income for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM net profit is $41.73 M
What is Cartesian Therapeutics TTM net income year-on-year change?
Over the past year, RNAC TTM net profit has changed by -$208.67 M (-577.09%)